Neurological morphofunctional differentiation induced by REAC technology in PC12: a neuro protective model for Parkinson's disease
| Autor: | Sara Santaniello, Margherita Maioli, Gaia Giovanna Maria Rocchitta, Carlo Ventura, Valentina Basoli, Rossana Migheli, Alessandro Castagna, Gianfranco Pigliaru, Salvatore Rinaldi, Vania Fontani, Pier Andrea Serra |
|---|---|
| Přispěvatelé: | Maioli, Margherita, Rinaldi, Salvatore, Migheli, Rossana, Pigliaru, Gianfranco, Rocchitta, Gaia, Santaniello, Sara, Basoli, Valentina, Castagna, Alessandro, Fontani, Vania, Ventura, Carlo, Serra, Pier Andrea |
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
Pathology
medicine.medical_specialty Parkinson's disease Deep brain stimulation Tyrosine 3-Monooxygenase genetic structures Deep Brain Stimulation medicine.medical_treatment Basic Helix-Loop-Helix Transcription Factor Electric Stimulation Therapy Nerve Tissue Proteins Biology PC12 Cells Neuroprotection Article Tubulin Cell Line Tumor Nerve Growth Factor BIO/14 Farmacologia Basic Helix-Loop-Helix Transcription Factors medicine Animals Electric stimulation therapy BIO/10 Biochimica Cell Proliferation Multidisciplinary Animal Dopaminergic Neurons Gene Expression Profiling Cell Differentiation Parkinson Disease medicine.disease PC12 Cell Rats Nerve Tissue Protein Rat Dopaminergic Neuron |
| Zdroj: | Scientific Reports |
| Popis: | Research for the use of physical means, in order to induce cell differentiation for new therapeutic strategies, is one of the most interesting challenges in the field of regenerative medicine and then in the treatment of neurodegenerative diseases, Parkinson’s disease (PD) included. The aim of this work is to verify the effect of the radio electric asymmetric conveyer (REAC) technology on the PC12 rat adrenal pheochromocytoma cell line, as they display metabolic features of PD. PC12 cells were cultured with a REAC regenerative tissue optimization treatment (TO-RGN) for a period ranging between 24 and 192 hours. Gene expression analysis of specific neurogenic genes, as neurogenin-1, beta3-tubulin and Nerve growth factor, together with the immunostaining analysis of the specific neuronal protein beta3-tubulin and tyrosine hydroxylase, shows that the number of cells committed toward the neurogenic phenotype was significantly higher in REAC treated cultures, as compared to control untreated cells. Moreover, MTT and Trypan blue proliferation assays highlighted that cell proliferation was significantly reduced in REAC TO-RGN treated cells. These results open new perspectives in neurodegenerative diseases treatment, particularly in PD. Further studies will be needed to better address the therapeutic potential of the REAC technology. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|